Biofil Chemicals (BIOFILCHEM) | Financial Analysis & Statements

Biofil Chemicals & Pharmaceuticals Ltd. | Small-cap | Healthcare

₹46.98

-0.04%

| Biofil Chemicals Stock Comparison:

No comparison data available

Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 334.0M

Gross Profit 20.9M 6.26%

Operating Income 4.7M 1.40%

Net Income 5.6M 1.67%

Balance Sheet Metrics

Total Assets 509.6M

Total Liabilities 321.8M

Shareholders Equity 187.8M

Debt to Equity 1.71

Cash Flow Metrics

Operating Cash Flow -55.8M

Free Cash Flow -20.2M

Revenue & Profitability Trend

Biofil Chemicals Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue	334.0M	400.4M	300.4M	223.8M	357.5M
Cost of Goods Sold	313.1M	375.1M	274.2M	194.6M	324.3M
Gross Profit	20.9M	25.3M	26.1M	29.2M	33.2M
Operating Expenses	4.6M	10.4M	8.2M	7.7M	8.1M
Operating Income	4.7M	4.2M	7.4M	9.0M	11.9M
Pre-tax Income	7.4M	8.7M	7.9M	10.1M	19.2M
Income Tax	1.8M	1.6M	2.3M	3.2M	6.8M
Net Income	5.6M	7.1M	5.6M	7.0M	12.4M
EPS (Diluted)	-	₹0.44	₹0.34	₹0.44	₹0.77

Income Statement Trend

Biofil Chemicals Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets	425.5M	384.1M	223.5M	93.1M	234.6M
Non-Current Assets	84.1M	86.8M	90.5M	94.2M	97.8M
Total Assets	509.6M	470.8M	314.1M	187.3M	332.4M
Liabilities
Current Liabilities	318.5M	285.2M	137.3M	14.9M	167.5M
Non-Current Liabilities	3.3M	3.6M	3.8M	4.0M	3.6M
Total Liabilities	321.8M	288.8M	141.0M	18.9M	171.1M
Equity
Total Shareholders Equity	187.8M	182.0M	173.0M	168.4M	161.3M

Balance Sheet Composition

Biofil Chemicals Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income	7.4M	8.7M	7.9M	10.1M	19.2M
Operating Cash Flow	-55.8M	-129.5M	-122.7M	149.1M	114.4M
Investing Activities
Capital Expenditures	-1.0M	-229.0K	-106.0K	-699.0K	-961.0K
Investing Cash Flow	-1.0M	-229.0K	-106.0K	-699.0K	-961.0K
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	-	82.6M	576.0K	348.0K	-
Free Cash Flow	-20.2M	23.7M	-1.2M	-2.9M	5.4M

Cash Flow Trend

Biofil Chemicals Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 136.74

Price to Book 4.12

Price to Sales 2.27

Profitability Ratios

Profit Margin 1.67%

Operating Margin 3.13%

Return on Equity 3.02%

Return on Assets 0.99%

Financial Health

Current Ratio 1.34

Debt to Equity 2.51

Beta 1.63

Per Share Data

EPS (TTM) ₹0.34

Book Value per Share ₹11.29

Revenue per Share ₹20.36

Financial data is updated regularly. All figures are in the company's reporting currency.